I usually put you on ignore, but your kind of a guilty pleasure so I actually looked today. What a joke.
1) You mock other posters for inferring that short posts effect price (which I agree with) but then say it is worrisome that their is a rash of bullish posts by one poster. What a joke.
2) You try to compare Gild with. 121 billion market cap to PCYC in regard to short ratios and price movement, why not look at INCY which is a more realistic comparison and reported today, they missed estimates but it was up 3.5 percent. PCYC short ratio as of April 15 was at 6 percent while INCY was at 7.
3) Finally, let's remember Webush came out with 225 target on Feb 23 and modeled 99.2 million in sales for this quarter.
I don't feel the least bit ignored. In fact, since I have apparently elicited one of your two posts during the last three months, I feel that you are shining your tiny spotlight on me and am flattered. You miss my point on short ratios, though. An earnings beat generally moves the stock dramatically if there is a substantial short position in place. If there had been a larger short position in GILD, it would have gone straight to 80 on earnings. GILD, incidentally, also had some fairly lofty price targets (with the exception of the Goldman-Sachs analyst). As for INCY, I own a much reduced position in it, having sold most of my shares @ 63. I frankly had forgotten that they reported earnings today. In fact, GILD and MDVN are the last biotechs I have substantial positions in. I will own some PCYC at the end of the day tomorrow, whether it goes up or down. But I'm not afraid of missing the rocketship to 225, Wedbush notwithstanding.